Authors
Valerie Vierkant, William Purvines, Ziyi Li, Ling Qi, Peyton Westbo, Xuehua Wang, Jeff R Jones, David Earnest, Jun Wang
Published in
Alcohol, clinical & experimental research. Volume 50. Issue 11.
Abstract
Disturbance of circadian rhythms is a hallmark of substance use disorders, with depressant drugs often causing soporific effects such as reduced sleep latency. The suprachiasmatic nucleus (SCN) of the hypothalamus is the central circadian pacemaker in mammals, regulating daily rhythms in physiology and behavior. However, the cellular mechanisms through which depressants alter SCN function remain poorly defined.
We used whole-cell patch clamp electrophysiology in coronal brain slices to examine how alcohol and opioids modulate excitatory glutamatergic transmission onto SCN neurons. Ethanol effects were examined acutely and following chronic exposure paradigms. Optogenetic stimulation was used to activate either retinohypothalamic tract (RHT) input or μ-opioid receptor-expressing (MOR+) terminals, and MOR agonists were used to assess opioid-mediated effects on synaptic transmission.
We show that acute application of ethanol enhances SCN firing rates during the inactive locomotor stage of circadian rhythms (daytime for rodents). In contrast, chronic alcohol exposure reduces glutamatergic drive. We also found that activating MOR+ terminals via an excitatory channelrhodopsin transgenically expressed in MOR+ neurons produced bidirectional modulation of SCN firing and that MOR+ inputs formed functional glutamatergic synapses onto SCN neurons. We also found that chronic alcohol consumption significantly altered MOR-dependent modulation of SCN neuronal activity, demonstrating an interaction between ethanol exposure and opioidergic signaling. Notably, MOR-mediated transmission could be suppressed by the MOR agonists DAMGO and fentanyl.
Together, these findings reveal that both alcohol and opioids modulate glutamatergic input to the SCN. This work establishes the SCN as a novel target of depressant substances and highlights glutamatergic transmission as a key point of vulnerability in circadian dysregulation associated with substance use.
PMID:
43009453
Bibliographic data and abstract were imported from PubMed on 11 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0